Abacus Global 2025 Q3 Earnings Net Income Surges 233.9% as Company Returns to Profitability

Abacus Global (ABL) reported record Q3 2025 results, with revenue surging 124% to $63 million and net income reversing from a $5.28 million loss to $7.08 million. The company raised full-year adjusted net income guidance to $80–$84 million, reflecting strong demand for longevity-based assets and disciplined capital allocation.

Revenue

Abacus Global’s total revenue jumped 123.7% year-over-year to $62.98 million in Q3 2025. This growth was driven by robust performance in its Life Solutions and Longevity Funds segments, as well as increased asset management fees from recent acquisitions. The company’s asset management division generated $8.6 million in revenue, supported by $102 million in new inflows, underscoring the success of strategic M&A activity.

Earnings/Net Income

The company returned to profitability with EPS of $0.07 in Q3 2025, reversing from a $0.07 loss in the prior-year period. Net income surged 233.9% to $7.08 million, a dramatic turnaround from a $5.28 million net loss in 2024 Q3. The company’s adjusted net income grew 60% to $23.6 million, highlighting strong operational recovery and margin expansion. The 233.9% net income swing and EPS reversal demonstrate the effectiveness of cost controls and strategic initiatives.

Price Action

Post-earnings, Abacus Global’s stock price surged 12.96% in a single trading day, 28.49% over the subsequent week, and 8.22% month-to-date. The stock’s performance reflects investor confidence in the company’s strategic direction and financial health.

CEO Commentary

CEO Jay Jackson emphasized confidence in Abacus’s long-term business model, recurring earnings, and capital strength. He highlighted the approval of a $0.20 annual dividend and $10 million share repurchase program as strategic moves to balance growth and shareholder returns. Jackson noted that recurring revenues are expected to approach 70% of total revenue over time, driven by capital inflows into longevity funds and expanding fee income.

Guidance

Abacus expects to fund the dividend and buyback program through cash on hand and free cash flow. The company anticipates maintaining liquidity to support origination, acquisitions, and capital returns while adhering to a disciplined growth framework. Forward-looking guidance includes recurring revenues approaching 70% of total revenue, with dividends capped at 25% of adjusted net income or 55% of recurring revenue.

Additional News

In the past three weeks, Abacus completed the acquisition of AccuQuote, an online life insurance brokerage, and executed a $50 million securitization of life insurance assets. These moves expanded its digital origination capabilities and validated its underwriting expertise. The board also authorized a $10 million share repurchase program and initiated a $0.20 annual dividend, signaling confidence in capital returns. Additionally, the company was added to the Russell 2000 and 3000 indexes, enhancing its market visibility.

Post-Earnings Price Action Review

Abacus Global’s stock experienced a sharp post-earnings rally, with a 12.96% surge on the day of the report and a 28.49% gain over the following week. Month-to-date, the stock climbed 8.22%, reflecting strong investor sentiment. The price action aligns with the company’s strategic milestones, including the dividend initiation and securitization success. Analysts attribute the momentum to improved financial metrics, such as the 124% revenue growth and 60% adjusted EBITDA increase, which demonstrate the company’s ability to capitalize on market demand for longevity-based assets. The stock’s performance also highlights the market’s recognition of Abacus’s disciplined capital allocation framework, including the $10 million buyback program and recurring revenue trajectory.

Additional News

Abacus Global’s recent acquisition of AccuQuote bolstered its digital origination platform, enabling faster policy acquisition and expanded client coverage. The $50 million securitization of life insurance assets marked a scalable funding mechanism and validated institutional demand for longevity-linked products. Additionally, the company’s inclusion in the Russell 2000 and 3000 indexes increased its exposure to institutional investors. The board’s authorization of a $0.20 annual dividend and $10 million share repurchase program underscores confidence in the company’s cash generation and long-term value creation. These initiatives, combined with the 10th consecutive quarter of beating consensus estimates, position Abacus to capitalize on its market leadership in alternative asset management.